Boer Daniel Anton de, Chief Executive Officer at ProQR Therapeutics, bought PRQR on Jul 31, 2026
Data as of Oct 16
▲ BUY$354K200,000 shares at $1.77Boer Daniel Anton de Chief Executive OfficerPRQR ProQR Therapeutics N.V.
- Traded
- Jul 31, 2026
- Disclosed
- Aug 3, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
PRQR since disclosure
−23.4%
Similar stocks (XLV) since disclosure
+8.9%
XLV — its sector index fund
Change in closing price from Aug 3, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.